Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJessica M. Fogelen_US
dc.contributor.authorSarah E. Hudelsonen_US
dc.contributor.authorSan San Ouen_US
dc.contributor.authorStephen Harten_US
dc.contributor.authorCarole Wallisen_US
dc.contributor.authorMariza G. Morgadoen_US
dc.contributor.authorShanmugam Saravananen_US
dc.contributor.authorSrikanth Tripathyen_US
dc.contributor.authorLaura Hovinden_US
dc.contributor.authorEstelle Piwowar-Manningen_US
dc.contributor.authorDevin Sabinen_US
dc.contributor.authorMarybeth McCauleyen_US
dc.contributor.authorTheresa Gambleen_US
dc.contributor.authorXinyi C. Zhangen_US
dc.contributor.authorJoseph J. Eronen_US
dc.contributor.authorJoel E. Gallanten_US
dc.contributor.authorJohnstone Kumwendaen_US
dc.contributor.authorJoseph Makhemaen_US
dc.contributor.authorNagalingeswaran Kumarasamyen_US
dc.contributor.authorSuwat Chariyalertsaken_US
dc.contributor.authorJames Hakimen_US
dc.contributor.authorSharlaa Badal-Faesenen_US
dc.contributor.authorVictor Akeloen_US
dc.contributor.authorMina C. Hosseinipouren_US
dc.contributor.authorBreno R. Santosen_US
dc.contributor.authorSheela V. Godboleen_US
dc.contributor.authorJose H. Pilottoen_US
dc.contributor.authorBeatriz Grinsztejnen_US
dc.contributor.authorRavindre Panchiaen_US
dc.contributor.authorKenneth H. Mayeren_US
dc.contributor.authorYing Q. Chenen_US
dc.contributor.authorMyron S. Cohenen_US
dc.contributor.authorSusan H. Eshlemanen_US
dc.description.abstract© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Early initiation of antiretroviral treatment (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 participants in the HIV Prevention Trials Network 052 trial who started ART at CD4 counts of 350-550 cells per cubic millimeter and failed ART by May 2011; 8.2% had baseline resistance and 35.3% had resistance at ART failure. High baseline viral load and less education were associated with emergence of resistance at ART failure. Resistance at ART failure was observed in 7 of 8 (87.5%) participants who started ART at lower CD4 cell counts.en_US
dc.titleBrief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trialen_US
article.title.sourcetitleJournal of Acquired Immune Deficiency Syndromesen_US
article.volume72en_US Johns Hopkins School of Medicineen_US Hutchinson Cancer Research Centeren_US Science & Technology Research Foundation, Inc.en_US Laboratoriesen_US Oswaldo Cruzen_US Gaitonde Centre for AIDS Research and Educationen_US Jalma Institute of Leprosy and other Mycobacterial Diseases Indiaen_US Facilitation Departmenten_US Facilitation Departmenten_US University of North Carolina at Chapel Hillen_US CARE Centeren_US of Malawi College of Medicineen_US Harvard AIDS Institute Partnershipen_US Medical Centre Indiaen_US Mai Universityen_US Huggins School of Medicineen_US of Witwatersranden_US Medical Research Instituteen_US of North Carolina Project Malawien_US Nossa Senhora da Conceicaoen_US AIDS Research Institute Indiaen_US Geral de Rio de Janeiroen_US Instituteen_US Medical Schoolen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.